A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. (OCHTQ.PK). Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.
Monday, January 7, 2013
Immune Response and 2013
I just wanted to thank the many people around the world who have visited and viewed my blog over the past year. Looking toward 2013 I will continue to work on behalf of my fellow investors in Immune Response/Orchestra Therapeutics and seek to protect our rights concerning Immune Response Biopharma. The research they now seek to exploit was financed and supported for nearly twenty years by investors including myself. Though they claim to be a new and separate company all their research was in fact conducted and financed more than ten years ago. Hopefully investors like myself will be able to convince Immune Response Biopharma to deal fairly with the original investors.
Subscribe to:
Posts (Atom)